Phase I study of human chorionic gonadotropin given subcutaneously to patients with acquired immunodeficiency syndrome-related mucocutaneous Kaposi's sarcoma

Journal of the National Cancer Institute

Volumn 89, Issue 23, 1997, Pages 1797-1802

  Gill, Parkash S ^a   McLaughlin, Tracy ^a,c   Espina, Byron M ^a   Tulpule, Anil ^a   Louie, Stan ^a   Lunardi Iskandar, Yanto ^b   Gallo, Robert C ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; LUTEINIZING HORMONE; TESTOSTERONE; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; ENERGY; HUMAN; KAPOSI SARCOMA; LIBIDO; MALE; PHASE 1 CLINICAL TRIAL; SIDE EFFECT; SUBCUTANEOUS DRUG ADMINISTRATION; WEIGHT GAIN;

EID: 0030656284     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.23.1797     Document Type: Article

References (20)

1. Centers for Disease Control and Prevention. HIV/AIDS surveillance report. February 1993: 1-23.
2. Hoover DR, Black C, Jacobsen LP, Martinez-Maza O, Seminara D, Saah A, et al. Epidemiologic analysis of Kaposi's sarcoma as an early and later AIDS outcome in homosexual men. Am J Epidemiol 1993;138:266-78.
3. Chak LY, Gill PS, Levine AM, Meyer PR, Anselmo JA, Petrovich Z. Radiation therapy for acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Clin Oncol 1988; 6:863-7.
4. Evans LM, Itri LM, Campion M, Wyler-Plaut R, Krown Se, Groopman JE, et al. Interferon-alpha 2a in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Immunother 1991;10:39-50.
5. Kovacs JA, Deyton L, Davey R, Falloon J, Zunich K, Lee D, et al. Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1989;111:280-7.
6. Gelmann EP, Longo D, Lane HC, Fauci AS, Masur H, Wesley M, et al. Combination chemotherapy of disseminated Kaposi's sarcoma in patients with the acquired immune deficiency syndrome. Am J Med 1987;82:456-62.
7. Gill PS, Rarick M, McCutchan JA, Slater L, Parker B, Muchmore E, et al. Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial. Am J Med 1991; 90:427-33.
8. Gill PS, Rarick M, Bernstein-Singer M, Harb M, Espina BM, Shaw V, et al. Treatment of advanced Kaposi's sarcoma using a combination of bleomycin and vincristine. Am J Clin Oncol 1990;13:315-9.
9. Gill PS, Miles SA, Mitsuyasu RT, Montgomery T, McCarthy S, Espina BM, et al. Phase I AIDS Clinical Trials Group (075) study of adriamycin, bleomycin and vincristine chemotherapy with zidovudine in the treatment of AIDS-related Kaposi's sarcoma. AIDS 1994;8: 1695-9.
10. Gill PS, Hamilton AW, Naidu Y. Epidemic (AIDS-related) Kaposi's sarcoma: epidemiology, pathogenesis, and treatment. AIDS Updates 1994;7:1-11.
11. Lunardi-Iskandar Y, Bryant JL, Zeman RA, Lam VH, Samiengo F, Besnier JM, et al. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone [published erratum appears in Nature 1995; 376:447]. Nature 1995;375:64-8.
12. Gill PS, Lunardi-Iskandar Y, Louie S, Tulpule A, Zheng T, Espina BM, et al. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. N Engl J Med 1996;335:1261-9.
13. Green S, Weiss GR. Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria. Invest New Drugs 1992; 10:239-53.
14. Mehta CR, Patel NR. A network algorithm for the exact treatment of Fisher's exact test in RxC contingency tables. J Am Stat Assoc 1983;78:427-34.
15. SAS Institute. Inc. SAS/STAT user's guide, release 6.03 edition. Cary (NC): SAS Institute, Inc., 1988:1028.
16. Harris PJ. Intramuscular administration of human chorionic gonadotropin to treat Kaposi's sarcoma. Patient Care and STD's 1996;10: 154-61.
17. Glass AR. Gynecomastia. Endocrinol Metab Clin North Am 1994;23:825-37.
18. Bourinbaiar AS, Nagorny R. Inhibitory effect of human chorionic gonadotropin (hCG) on HIV-1 transmission from lymphocytes to trophoblasts. FEBS Lett 1992;309:82-4.
19. Jones TH, Darne JF, McGarrigle HH. Diurnal rhythm of testosterone induced by human chorionic gonadotropin (hCG) therapy in isolated hypogonadotrophic hypogonadism: a comparison between subcutaneous and intramuscular hCG administration. Eur J Endocrinol 1994; 131:173-8.
20. Saal W, Glowania HJ, Hengst W, Happ J. Pharmacodynamics and pharmacokinetics after subcutaneous and intramuscular injection of human chorionic gonadotropin. Fertil Steril 1991;56:225-9.